1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LUMOS PHARMA INC

Lumos Pharma Inc

XNAS: LUMO

Watchlist

Portfolio

Share


Insider Trading disclosures for Lumos Pharma Inc

The latest disclosure was made by John C. McKew in Lumos Pharma Inc where a trade of 3,407 Common Stock done at an average price of $1.9 was reported to US exchanges on Aug. 6, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
John C. McKew Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.89 per share. 06 Aug 2024 3,407 12,653 (0%) 0% 1.9 6,426 Common Stock
Lori Lawley Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.79 per share. 01 Aug 2024 229 12,284 (0%) 0% 1.8 410 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.79 per share. 01 Aug 2024 1,593 16,060 (0%) 0% 1.8 2,851 Common Stock
Pisit Duke Pitukcheewanont Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.26 per share. 01 Jul 2024 274 16,836 (0%) 0% 2.3 620 Common Stock
Lota S. Zoth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 3,328 3,328 - - Stock Option (Right to Buy)
Thomas A. Raffin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 3,328 3,328 - - Stock Option (Right to Buy)
Kevin M. Lalande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 3,328 3,328 - - Stock Option (Right to Buy)
Joseph S. McCracken Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 3,328 3,328 - - Stock Option (Right to Buy)
Chad A. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 3,328 3,328 - - Stock Option (Right to Buy)
Pisit Duke Pitukcheewanont Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.25 per share. 01 Jun 2024 320 16,610 (0%) 0% 2.3 720 Common Stock
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 11,000 11,000 - - Stock Option (Right to Buy)
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 2.84 per share. 01 Apr 2024 4,500 754,615 (2%) 0% 2.8 12,780 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 35,400 35,400 - - Stock Option (Right to Buy)
Richard J. Hawkins Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.84 per share. 01 Apr 2024 1,522 753,093 (2%) 0% 2.8 4,322 Common Stock
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 16,000 16,000 - - Stock Option (Right to Buy)
John C. McKew Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 2.78 per share. 01 Apr 2024 2,214 17,153 (0%) 0% 2.8 6,144 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.84 per share. 01 Apr 2024 1,036 19,367 (0%) 0% 2.8 2,942 Common Stock
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 2.84 per share. 01 Apr 2024 2,000 20,403 (0%) 0% 2.8 5,680 Common Stock
Lori Lawley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 12,000 12,000 - - Stock Option (Right to Buy)
Lori Lawley Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.84 per share. 01 Apr 2024 274 12,513 (0%) 0% 2.8 778 Common Stock
Lori Lawley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 2.84 per share. 01 Apr 2024 1,000 12,787 (0%) 0% 2.8 2,840 Common Stock
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 2.84 per share. 01 Apr 2024 900 6,649 (0%) 0% 2.8 2,556 Common Stock
Bradley J. Powers General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.84 per share. 01 Apr 2024 342 6,307 (0%) 0% 2.8 971 Common Stock
Pisit Duke Pitukcheewanont Chief Medical Officer Grant, award, or other acquisition of securities at price $ 2.84 per share. 01 Apr 2024 6,000 16,930 (0%) 0% 2.8 17,040 Common Stock
Pisit Duke Pitukcheewanont Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 41,500 41,500 - - Stock Option (Right to Buy)
John McKew C. Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.03 per share. 06 Feb 2024 438 18,403 (0%) 0% 3.0 1,328 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.01 per share. 01 Feb 2024 366 18,841 (0%) 0% 3.0 1,102 Common Stock
Richard Hawkins J. Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.01 per share. 01 Feb 2024 690 750,115 (2%) 0% 3.0 2,077 Common Stock
Lori Lawley Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.01 per share. 01 Feb 2024 215 11,787 (0%) 0% 3.0 647 Common Stock
Bradley J. Powers General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.01 per share. 01 Feb 2024 240 5,749 (0%) 0% 3.0 722 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.28 per share. 01 Aug 2023 1,593 22,114 (0%) 0% 3.3 5,225 Common Stock
John C. McKew Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.20 per share. 01 Aug 2023 3,407 18,707 (0%) 0% 3.2 10,919 Common Stock
Lori Lawley Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.28 per share. 01 Aug 2023 229 11,502 (0%) 0% 3.3 751 Common Stock
Lota S. Zoth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 3,345 3,345 - - Stock Option (Right to Buy)
Thomas A. Raffin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 3,345 3,345 - - Stock Option (Right to Buy)
Kevin M. Lalande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 3,345 3,345 - - Stock Option (Right to Buy)
Joseph S. McCracken Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 3,345 3,345 - - Stock Option (Right to Buy)
Chad A. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 3,345 3,345 - - Stock Option (Right to Buy)
Richard J. Hawkins Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.31 per share. 01 Apr 2023 1,522 750,805 (2%) 0% 3.3 5,038 Common Stock
John C. McKew Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.27 per share. 01 Apr 2023 2,214 23,207 (0%) 0% 3.3 7,240 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.31 per share. 01 Apr 2023 1,036 25,421 (0%) 0% 3.3 3,429 Common Stock
Lori Lawley Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.31 per share. 01 Apr 2023 274 11,231 (0%) 0% 3.3 907 Common Stock
Bradley J. Powers General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.31 per share. 01 Apr 2023 342 5,989 (0%) 0% 3.3 1,132 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.52 per share. 01 Feb 2023 416 752,327 (2%) 0% 3.5 1,464 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 3.52 per share. 01 Feb 2023 4,500 752,743 (2%) 0% 3.5 15,840 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 35,400 35,400 - - Stock Option (Right to Buy)
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 3.52 per share. 01 Feb 2023 2,000 27,102 (0%) 0% 3.5 7,040 Common Stock
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 16,000 16,000 - - Stock Option (Right to Buy)
John C. McKew Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.53 per share. 01 Feb 2023 439 26,457 (0%) 0% 3.5 1,550 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.52 per share. 01 Feb 2023 206 26,896 (0%) 0% 3.5 725 Common Stock
Lori Lawley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.52 per share. 01 Feb 2023 1,000 11,619 (0%) 0% 3.5 3,520 Common Stock
Lori Lawley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 12,000 12,000 - - Stock Option (Right to Buy)
Lori Lawley Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.52 per share. 01 Feb 2023 114 11,505 (0%) 0% 3.5 401 Common Stock
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 3.52 per share. 01 Feb 2023 900 6,462 (0%) 0% 3.5 3,168 Common Stock
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 11,000 11,000 - - Stock Option (Right to Buy)
Bradley J. Powers General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.52 per share. 01 Feb 2023 131 6,331 (0%) 0% 3.5 461 Common Stock
David B. Karpf Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 12,000 12,000 - - Stock Option (Right to Buy)
David B. Karpf Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. 01 Feb 2023 36 8,294 (0%) 0% 3.5 127 Common Stock
David B. Karpf Chief Medical Officer Grant, award, or other acquisition of securities at price $ 3.52 per share. 01 Feb 2023 1,000 8,330 (0%) 0% 3.5 3,520 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 8.75 per share. 19 Sep 2022 1,506 2,047 (0%) 0% 8.8 13,178 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 8.65 per share. 19 Sep 2022 541 541 (0%) 0% 8.7 4,680 Common Stock
David B. Karpf Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.53 per share. 01 Sep 2022 570 7,330 (0%) 0% 8.5 4,862 Common Stock
Thomas A. Raffin Director Purchase of securities on an exchange or from another person at price $ 8.46 per share. 25 Aug 2022 1,150 9,406 (0%) 0% 8.5 9,729 Common Stock
Joseph S. McCracken Director Purchase of securities on an exchange or from another person at price $ 8.60 per share. 25 Aug 2022 3,170 11,721 (0%) 0% 8.6 27,262 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.17 per share. 01 Aug 2022 1,593 28,009 (0%) 0% 8.2 13,015 Common Stock
John C. McKew Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 8.11 per share. 01 Aug 2022 3,407 24,602 (0%) 0% 8.1 27,631 Common Stock
Lori Lawley Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.17 per share. 01 Aug 2022 229 10,119 (0%) 0% 8.2 1,871 Common Stock
John C. McKew Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.62 per share. 06 Jun 2022 169 29,102 (0%) 0% 7.6 1,288 Common Stock
Lota S. Zoth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 3,431 3,431 - - Stock Option (Right to Buy)
Thomas A. Raffin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 3,431 3,431 - - Stock Option (Right to Buy)
Kevin M. Lalande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 3,431 3,431 - - Stock Option (Right to Buy)
Joseph S. McCracken Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 3,431 3,431 - - Stock Option (Right to Buy)
Chad A. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 3,431 3,431 - - Stock Option (Right to Buy)
Richard J. Hawkins Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.23 per share. 01 Apr 2022 1,466 748,243 (2%) 0% 9.2 13,531 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.23 per share. 01 Apr 2022 1,036 31,485 (0%) 0% 9.2 9,562 Common Stock
John C. McKew Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 8.32 per share. 01 Apr 2022 2,214 29,271 (0%) 0% 8.3 18,420 Common Stock
Lori Lawley Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.23 per share. 01 Apr 2022 274 9,848 (0%) 0% 9.2 2,529 Common Stock
Bradley J. Powers General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.23 per share. 01 Apr 2022 342 5,562 (0%) 0% 9.2 3,157 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 35,400 35,400 - - Stock Option (Right to Buy)
Richard J. Hawkins Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.02 per share. 01 Feb 2022 173 749,709 (2%) 0% 10.0 1,733 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 10.02 per share. 01 Feb 2022 4,500 749,882 (2%) 0% 10.0 45,090 Common Stock
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 14,000 14,000 - - Stock Option (Right to Buy)
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 10.02 per share. 01 Feb 2022 1,500 32,621 (0%) 0% 10.0 15,030 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.02 per share. 01 Feb 2022 100 32,521 (0%) 0% 10.0 1,002 Common Stock
Lori Lawley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 10.02 per share. 01 Feb 2022 1,000 10,187 (0%) 0% 10.0 10,020 Common Stock
Lori Lawley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 12,000 12,000 - - Stock Option (Right to Buy)
Lori Lawley Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.02 per share. 01 Feb 2022 65 10,122 (0%) 0% 10.0 651 Common Stock
Bradley J. Powers General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.03 per share. 01 Feb 2022 78 5,904 (0%) 0% 10.0 782 Common Stock
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 11,000 11,000 - - Stock Option (Right to Buy)
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 10.02 per share. 01 Feb 2022 900 5,982 (0%) 0% 10.0 9,018 Common Stock
David B. Karpf Chief Medical Officer Grant, award, or other acquisition of securities at price $ 10.02 per share. 01 Feb 2022 400 7,900 (0%) 0% 10.0 4,008 Common Stock
David B. Karpf Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 5,000 5,000 - - Stock Option (Right to Buy)
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 11.11 per share. 02 Sep 2021 10,000 720,446 (1%) 0% 11.1 111,139 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 11.35 per share. 02 Sep 2021 8,100 710,446 (1%) 0% 11.3 91,905 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 11.23 per share. 02 Sep 2021 6,300 702,346 (1%) 0% 11.2 70,739 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 10.70 per share. 30 Aug 2021 6,000 691,457 (1%) 0% 10.7 64,181 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 10.87 per share. 30 Aug 2021 4,589 696,046 (1%) 0% 10.9 49,892 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 10.52 per share. 30 Aug 2021 8,625 685,457 (1%) 0% 10.5 90,738 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 10.07 per share. 25 Aug 2021 6,200 672,851 (1%) 0% 10.1 62,430 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 10.50 per share. 25 Aug 2021 4,981 677,832 (1%) 0% 10.5 52,282 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 9.87 per share. 25 Aug 2021 14,900 666,651 (1%) 0% 9.9 147,078 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 9.58 per share. 20 Aug 2021 37,800 640,976 (1%) 0% 9.6 362,150 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 9.45 per share. 20 Aug 2021 10,775 651,751 (1%) 0% 9.5 101,871 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 8.73 per share. 20 Aug 2021 35,679 603,176 (1%) 0% 8.7 311,638 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 8.73 per share. 17 Aug 2021 28,870 547,497 (1%) 0% 8.7 252,009 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 8.45 per share. 17 Aug 2021 20,000 567,497 (1%) 0% 8.4 168,970 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 8.47 per share. 17 Aug 2021 16,000 518,627 (1%) 0% 8.5 135,446 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 7.86 per share. 12 Aug 2021 31,000 471,627 (1%) 0% 7.9 243,744 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 7.96 per share. 12 Aug 2021 31,000 502,627 (1%) 0% 8.0 246,717 Common Stock
Kevin M. Lalande Director Purchase of securities on an exchange or from another person at price $ 7.55 per share. 12 Aug 2021 31,000 440,627 (1%) 0% 7.5 233,932 Common Stock
Joseph S. McCracken Director Purchase of securities on an exchange or from another person at price $ 7.55 per share. 11 Aug 2021 7,475 8,551 (0%) 0% 7.5 56,406 Common Stock
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2021 20,000 33,226 (0%) 0% 0 Common Stock
Lori Lawley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2021 3,750 9,187 (0%) 0% 0 Common Stock
Lori Lawley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2021 21,250 21,250 - - Stock Option (Right to Buy)
Lota S. Zoth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 2,910 2,910 - - Stock Option (Right to Buy)
Lota S. Zoth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 367 2,187 (0%) 0% 0 Common Stock
Thomas A. Raffin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 2,910 2,910 - - Stock Option (Right to Buy)
Thomas A. Raffin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 367 8,256 (0%) 0% 0 Common Stock
Kevin M. Lalande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 2,910 2,910 - - Stock Option (Right to Buy)
Kevin M. Lalande Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 367 1,076 (0%) 0% 0 Common Stock
Joseph S. McCracken Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 2,910 2,910 - - Stock Option (Right to Buy)
Joseph S. McCracken Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 367 1,076 (0%) 0% 0 Common Stock
Chad A. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 367 1,076 (0%) 0% 0 Common Stock
Chad A. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 2,910 2,910 - - Stock Option (Right to Buy)
Richard J. Hawkins Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.25 per share. 01 Apr 2021 1,522 745,382 (1%) 0% 12.3 18,645 Common Stock
Carl W. Langren Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.25 per share. 01 Apr 2021 683 11,494 (0%) 0% 12.3 8,367 Common Stock
John C. McKew Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.25 per share. 01 Apr 2021 1,036 13,226 (0%) 0% 12.3 12,691 Common Stock
Lori Lawley Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.25 per share. 01 Apr 2021 274 5,437 (0%) 0% 12.3 3,357 Common Stock
Bradley J. Powers General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.25 per share. 01 Apr 2021 342 5,082 (0%) 0% 12.3 4,190 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 28,475 28,475 - - Stock Option (Right to Buy)
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 2,329 746,904 (2%) 0% 0 Common Stock
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 11,475 11,475 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 939 12,177 (0%) 0% 0 Common Stock
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 1,078 14,262 (0%) 0% 0 Common Stock
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 33,175 33,175 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 31,475 31,475 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 939 11,423 (0%) 0% 0 Common Stock
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 10,625 10,625 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 869 5,711 (0%) 0% 0 Common Stock
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 869 5,424 (0%) 0% 0 Common Stock
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 10,625 10,625 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 5,684 5,684 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 709 1,820 (0%) 0% 0 Common Stock
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 5,684 5,684 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 709 7,889 (0%) 0% 0 Common Stock
Kevin M. Lalande None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 709 709 (0%) 0% 0 Common Stock
Kevin M. Lalande None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 5,684 5,684 - - Stock Option (Right to Buy)
Joseph S. McCracken None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 709 709 (0%) 0% 0 Common Stock
Joseph S. McCracken None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 5,684 5,684 - - Stock Option (Right to Buy)
Emmett Cunningham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 5,684 5,684 - - Stock Option (Right to Buy)
Emmett Cunningham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 709 709 (0%) 0% 0 Common Stock
Chad A. Johnson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 5,684 5,684 - - Stock Option (Right to Buy)
Chad A. Johnson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 709 709 (0%) 0% 0 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 25,000 744,575 (1%) 0% 0 Common Stock
Richard J. Hawkins Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 135,000 135,000 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 45,000 45,000 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 9,000 11,238 (0%) 0% 0 Common Stock
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 65,000 65,000 - - Stock Option (Right to Buy)
John C. McKew Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 13,000 13,000 (0%) 0% 0 Common Stock
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 9,000 10,484 (0%) 0% 0 Common Stock
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 45,000 45,000 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 4,500 4,842 (0%) 0% 0 Common Stock
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 25,000 25,000 - - Stock Option (Right to Buy)
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 25,000 25,000 - - Stock Option (Right to Buy)
Bradley J. Powers General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2020 4,500 4,555 (0%) 0% 0 Common Stock
Carl W. Langren Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.21 per share. 04 Jan 2020 281 20,144 (0%) 0% 2.2 621 Common Stock
Eugene P. Kennedy Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.21 per share. 04 Jan 2020 376 13,721 (0%) 0% 2.2 831 Common Stock
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 2,100 10,006 (0%) 0% 0 Common Stock
Bradley J. Powers Principal Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.59 per share. 24 Aug 2019 76 503 (0%) 0% 1.6 121 Common Stock
Charles J. Link Director, Chairman of the Board and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2019 331,258 331,258 - - Stock Option (Right to Buy)
Lota S. Zoth None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 13,309 0 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 5,220 5,220 - - Stock Option (Right to Buy)
Lota S. Zoth None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 15,659 0 - - Stock Option (Right to Buy)
Lota S. Zoth None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 10,713 0 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,968 3,968 - - Stock Option (Right to Buy)
Lota S. Zoth None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 11,904 0 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,437 4,437 - - Stock Option (Right to Buy)
Lota S. Zoth None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 27,777 0 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 13,889 13,889 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,000 4,000 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 12,000 0 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,571 3,571 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,392 2,392 - - Stock Option (Right to Buy)
Lota S. Zoth None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 4,783 0 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 8,887 8,887 - - Stock Option (Right to Buy)
Lota S. Zoth None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 17,773 0 - - Stock Option (Right to Buy)
Lota S. Zoth None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 6,349 0 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,588 1,588 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 5,269 5,269 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 312,500 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 48,828 48,828 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 25,820 25,820 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 19,532 19,532 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 19,532 19,532 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 19,531 19,531 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 19,531 19,531 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,477 3,477 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 126,500 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 10,542 10,542 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 14,926 14,926 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 7,907 7,907 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 7,907 7,907 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 6,158 6,158 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 5,275 5,275 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 5,269 5,269 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 100,000 100,000 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 190 190 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,195 2,195 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 18,246 18,246 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 84,275 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 813 813 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 19,438 19,438 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 81,000 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,710 1,710 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 22,041 22,041 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 71,250 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,129 3,129 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 26,872 26,872 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 90,000 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 8,080 8,080 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 31,921 31,921 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 80,000 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 7,143 7,143 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 14,286 14,286 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 42,857 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 95,238 95,238 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 190,476 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 22,580 22,580 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 167,896 167,896 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 380,952 0 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 439 439 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 47,619 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,786 1,786 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 3,571 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 8,929 8,929 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 17,857 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 13,095 13,095 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 26,190 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 17,774 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 8,887 8,887 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 4,782 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,391 2,391 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 13,309 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,437 4,437 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 27,777 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 13,889 13,889 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 23,810 23,810 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 17,855 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 5,952 5,952 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 12,000 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,000 4,000 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 15,659 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 5,220 5,220 - - Stock Option (Right to Buy)
Thomas A. Raffin None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 6,349 0 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,588 1,588 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 5,952 5,952 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 23,809 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 11,905 11,905 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 23,809 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 11,905 11,905 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 11,904 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 2,380 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,190 1,190 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 11,902 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,968 3,968 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 12,000 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,000 4,000 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 15,659 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 5,220 5,220 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 6,349 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,588 1,588 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 17,774 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 8,887 8,887 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 4,782 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,391 2,391 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 13,309 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,437 4,437 - - Stock Option (Right to Buy)
Ernest J. Talarico None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 27,777 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 13,889 13,889 - - Stock Option (Right to Buy)
Matthew L. Sherman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 13,889 13,889 - - Stock Option (Right to Buy)
Matthew L. Sherman None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 27,777 0 - - Stock Option (Right to Buy)
Matthew L. Sherman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 18,506 18,506 - - Stock Option (Right to Buy)
Matthew L. Sherman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 13,218 13,218 - - Stock Option (Right to Buy)
Matthew L. Sherman None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 63,447 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 278 278 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 330 330 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 100,000 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,291 2,291 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,291 2,291 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,293 2,293 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,438 3,438 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,438 3,438 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,297 4,297 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,870 4,870 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,583 4,583 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 55,000 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,821 4,821 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,211 2,211 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 11,719 11,719 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 37,500 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,639 1,639 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 328 328 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 281 281 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 20,000 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 9,392 9,392 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 14,293 14,293 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 24,250 24,250 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 11,458 11,458 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 2,380 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,190 1,190 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 16,666 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 8,333 8,333 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 23,809 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 9,038 9,038 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,867 2,867 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 15,000 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 5,472 5,472 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,028 2,028 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 20,000 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,539 3,539 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,129 3,129 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 27,000 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 6,692 6,692 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,309 2,309 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 16,300 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,487 3,487 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 589 589 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 8,989 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 66 66 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 50,000 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 24,306 24,306 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 695 695 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 50,000 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,826 4,826 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,550 4,550 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 73 73 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 177 177 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 250 250 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 1,000 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 15,625 15,625 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 37,500 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 7,813 7,813 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 6,641 6,641 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,297 4,297 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 110,000 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 9,167 9,167 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 15,889 15,889 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 6,875 6,875 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 6,875 6,875 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,587 4,587 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,582 4,582 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,582 4,582 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,445 2,445 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 50,000 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 16,667 16,667 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 50,000 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 11,944 11,944 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 4,724 4,724 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 30,000 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 7,032 7,032 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 469 469 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 10,000 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,326 2,326 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 174 174 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 10,000 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,188 2,188 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 313 313 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 12,641 0 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 2,525 2,525 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 330 330 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 241 241 - - Stock Option (Right to Buy)
Chad A. Johnson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 13,889 13,889 - - Stock Option (Right to Buy)
Chad A. Johnson None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 48,324 0 - - Stock Option (Right to Buy)
Chad A. Johnson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 10,739 10,739 - - Stock Option (Right to Buy)
Chad A. Johnson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 13,424 13,424 - - Stock Option (Right to Buy)
Chad A. Johnson None Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 27,777 0 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 98 98 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 563 563 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 187 187 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 105 105 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,250 1,250 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 3,021 3,021 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 729 729 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 10,000 0 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 360 360 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 311 311 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 115 115 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 2,352 0 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 70 70 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 487 487 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,111 1,111 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 3,334 0 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 98 98 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 472 472 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 2,000 0 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 868 868 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 1,633 1,633 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 10,000 0 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2019 2,000 0 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 146 146 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.57 per share. 23 Jun 2019 359 14,097 (0%) 0% 1.6 564 Common Stock
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2019 25,000 25,000 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2019 25,000 25,000 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2019 25,000 25,000 - - Stock Option (Right to Buy)
Matthew L. Sherman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2019 25,000 25,000 - - Stock Option (Right to Buy)
Chad A. Johnson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2019 25,000 25,000 - - Stock Option (Right to Buy)
Charles J. Link Director, Chairman of the Board and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2019 500,000 500,000 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2019 185,000 185,000 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2019 185,000 185,000 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2019 185,000 185,000 - - Stock Option (Right to Buy)
Lori Lawley Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2019 50,000 50,000 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. 04 Jan 2019 376 13,516 (0%) 0% 1.6 583 Common Stock
Charles J. Link Director, Chairman of the Board and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. 02 Jan 2019 5,906 250,801 (0%) 0% 1.5 9,154 Common Stock
Charles J. Link Director, Chairman of the Board and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. 02 Jan 2019 5,699 256,707 (0%) 0% 1.7 9,460 Common Stock
Nicholas N. Vahanian President Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. 02 Jan 2019 2,229 51,179 (0%) 0% 1.7 3,700 Common Stock
Nicholas N. Vahanian President Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. 02 Jan 2019 2,626 48,553 (0%) 0% 1.5 4,070 Common Stock
Carl W. Langren Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. 02 Jan 2019 398 20,425 (0%) 0% 1.6 617 Common Stock
Carl W. Langren Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. 02 Jan 2019 646 20,823 (0%) 0% 1.7 1,072 Common Stock
Charles J. Link Director, Chairman of the Board and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2018 2,564 0 - - Stock Option (Right to Buy)
Charles J. Link Director, Chairman of the Board and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.80 per share. 12 Dec 2018 2,564 262,406 (0%) 0% 0.8 2,051 Common Stock
Carl W. Langren Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2018 2,564 0 - - Stock Option (Right to Buy)
Carl W. Langren Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.80 per share. 12 Dec 2018 2,564 21,469 (0%) 0% 0.8 2,051 Common Stock
John B. Henneman Chief Administrative Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.28 per share. 01 Oct 2018 2,484 55,052 (0%) 0% 2.3 5,664 Common Stock
Carl W. Langren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2018 100,000 100,000 - - Stock Option (Right to Buy)
Ernest J. Talarico None Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 10 Jul 2018 3,093 46,029 (0%) 0% 2.1 6,495 Common Stock
Ernest J. Talarico None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2018 7,142 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2018 3,571 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2018 3,093 0 - - Stock Option (Right to Buy)
Ernest J. Talarico None Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 10 Jul 2018 7,142 39,365 (0%) 0% 2.1 14,998 Common Stock
Ernest J. Talarico None Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 10 Jul 2018 3,571 42,936 (0%) 0% 2.1 7,499 Common Stock
Ernest J. Talarico None Sale of securities on an exchange or to another person at price $ 4.82 per share. 10 Jul 2018 13,806 32,223 (0%) 0% 4.8 66,600 Common Stock
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 27,777 27,777 - - Stock Option (Right to Buy)
Paolo Pucci None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 27,777 27,777 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 27,777 27,777 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 27,777 27,777 - - Stock Option (Right to Buy)
Matthew L. Sherman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 27,777 27,777 - - Stock Option (Right to Buy)
Chad A. Johnson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 27,777 27,777 - - Stock Option (Right to Buy)
John B. Henneman EVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 122,000 122,000 - - Stock Option (Right to Buy)
Charles J. Link Director, Chairman of the Board and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 310,000 310,000 - - Stock Option (Right to Buy)
Nicholas N. Vahanian President, Chief Medical Offic Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 126,500 126,500 - - Stock Option (Right to Buy)
Brian Wiley Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 110,000 110,000 - - Stock Option (Right to Buy)
Carl W. Langren Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 55,000 55,000 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 110,000 110,000 - - Stock Option (Right to Buy)
Eugene P. Kennedy Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.62 per share. 20 Jan 2018 85 13,892 (0%) 0% 8.6 733 Common Stock
Eugene P. Kennedy Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.06 per share. 04 Jan 2018 409 13,977 (0%) 0% 10.1 4,115 Common Stock
John B. Henneman EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.47 per share. 02 Jan 2018 164 58,859 (0%) 0% 8.5 1,389 Common Stock
John B. Henneman EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.06 per share. 02 Jan 2018 1,323 57,536 (0%) 0% 10.1 13,309 Common Stock
Charles J. Link Director, Chairman of the Board and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.06 per share. 02 Jan 2018 5,541 259,842 (0%) 0% 10.1 55,742 Common Stock
Charles J. Link Director, Chairman of the Board and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.47 per share. 02 Jan 2018 8,939 265,383 (0%) 0% 8.5 75,713 Common Stock
Nicholas N. Vahanian President, Chief Medical Offic Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.06 per share. 02 Jan 2018 2,659 53,408 (0%) 0% 10.1 26,750 Common Stock
Nicholas N. Vahanian President, Chief Medical Offic Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.47 per share. 02 Jan 2018 3,866 56,067 (0%) 0% 8.5 32,745 Common Stock
Brian Wiley Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.47 per share. 02 Jan 2018 1,237 18,753 (0%) 0% 8.5 10,477 Common Stock
Brian Wiley Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.06 per share. 02 Jan 2018 603 18,150 (0%) 0% 10.1 6,066 Common Stock
Carl W. Langren Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.47 per share. 02 Jan 2018 883 19,162 (0%) 0% 8.5 7,479 Common Stock
Carl W. Langren Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.06 per share. 02 Jan 2018 257 18,905 (0%) 0% 10.1 2,585 Common Stock
Carl W. Langren Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Nov 2017 9,523 0 - - Stock Option (Right to Buy)
Carl W. Langren Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 9.05 per share. 21 Nov 2017 2,229 19,666 (0%) 0% 9.0 20,172 Common Stock
Carl W. Langren Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 21 Nov 2017 9,523 21,895 (0%) 0% 2.1 19,998 Common Stock
John B. Henneman EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.18 per share. 01 Oct 2017 2,789 56,544 (0%) 0% 10.2 28,392 Common Stock
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2017 13,309 13,309 - - Stock Option (Right to Buy)
Paolo Pucci None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2017 13,309 13,309 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2017 13,309 13,309 - - Stock Option (Right to Buy)
Joseph B. Saluri None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2017 13,309 13,309 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2017 13,309 13,309 - - Stock Option (Right to Buy)
Paul R. Edick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2017 13,309 13,309 - - Stock Option (Right to Buy)
John B. Henneman EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.04 per share. 03 Jan 2017 1,323 58,612 (0%) 0% 11.0 14,606 Common Stock
John B. Henneman EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.28 per share. 03 Jan 2017 164 59,935 (0%) 0% 10.3 1,686 Common Stock
John B. Henneman EVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2017 137,500 137,500 - - Stock Option (Right to Buy)
Charles J. Link Director, Chairman of the Board and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.28 per share. 03 Jan 2017 5,265 277,491 (0%) 0% 10.3 54,124 Common Stock
Charles J. Link Director, Chairman of the Board and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2017 326,288 326,288 - - Stock Option (Right to Buy)
Charles J. Link Director, Chairman of the Board and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.04 per share. 03 Jan 2017 3,169 274,322 (0%) 0% 11.0 34,986 Common Stock
Nicholas N. Vahanian President, Chief Medical Offic Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.04 per share. 03 Jan 2017 2,085 59,933 (0%) 0% 11.0 23,018 Common Stock
Nicholas N. Vahanian President, Chief Medical Offic Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.28 per share. 03 Jan 2017 3,266 62,018 (0%) 0% 10.3 33,574 Common Stock
Nicholas N. Vahanian President, Chief Medical Offic Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2017 312,500 312,500 - - Stock Option (Right to Buy)
Brian Wiley Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.04 per share. 03 Jan 2017 603 19,271 (0%) 0% 11.0 6,657 Common Stock
Brian Wiley Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.28 per share. 03 Jan 2017 1,237 19,874 (0%) 0% 10.3 12,716 Common Stock
Brian Wiley Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2017 75,000 75,000 - - Stock Option (Right to Buy)
Carl W. Langren Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.28 per share. 03 Jan 2017 883 9,808 (0%) 0% 10.3 9,077 Common Stock
Carl W. Langren Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2017 37,500 37,500 - - Stock Option (Right to Buy)
Carl W. Langren Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.04 per share. 03 Jan 2017 257 9,551 (0%) 0% 11.0 2,837 Common Stock
Carl W. Langren Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Dec 2016 3,943 10,691 - - Common Stock
John B. Henneman EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 01 Oct 2016 2,789 60,099 - - Common Stock
John B. Henneman EVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 150,000 150,000 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 17,773 17,773 - - Stock Option (Right to Buy)
Lota S. Zoth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 4,783 4,783 - - Stock Option (Right to Buy)
Paolo Pucci None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 17,773 17,773 - - Stock Option (Right to Buy)
Paolo Pucci None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 4,783 4,783 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 17,774 17,774 - - Stock Option (Right to Buy)
Thomas A. Raffin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 4,782 4,782 - - Stock Option (Right to Buy)
Joseph B. Saluri None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 17,773 17,773 - - Stock Option (Right to Buy)
Joseph B. Saluri None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 4,783 4,783 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 17,774 17,774 - - Stock Option (Right to Buy)
Ernest J. Talarico None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 4,782 4,782 - - Stock Option (Right to Buy)
Paul R. Edick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 17,773 17,773 - - Stock Option (Right to Buy)
Paul R. Edick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 4,783 4,783 - - Stock Option (Right to Buy)
Brian Wiley Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 30,000 30,000 - - Stock Option (Right to Buy)
Carl W. Langren Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2016 20,000 20,000 - - Stock Option (Right to Buy)
Ernest J. Talarico None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2016 4,065 32,223 - - Common Stock
Charles J. Link Director, Chairman of the Board and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Apr 2016 10,000 282,756 - - Common Stock
Charles J. Link Director, Chairman of the Board and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Mar 2016 20,000 297,756 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters